Alpha IVF Group

What Alpha IVF Group does

Alpha IVF Group Berhad is a Malaysia-headquartered fertility healthcare group that operates owned-and-operated IVF clinics and women's specialist centres across five markets: Malaysia, Singapore, Indonesia, the Philippines, and China. The group was founded in 2009 and listed on Bursa Malaysia's ACE Market in March 2024 under ticker KL:ALPHA. Its core service is assisted reproductive technology, including IVF, ICSI, Preimplantation Genetic Testing (PGT-A/M/HLA), sperm sorting (MicroSort), egg freezing, and In-Vitro Activation for low ovarian reserve, delivered across flagship centres in Kuala Lumpur, Penang, Kota Kinabalu, Singapore, and Manila, supported by satellite referral clinics in Jakarta, Surabaya, Medan, and sales offices in Shanghai and Guangzhou.

The group's clinical technology stack is built around several proprietary and first-in-region capabilities: PIEZO-ICSI (89% fertilisation rate, 1% egg degeneration), CRYOTEC cryopreservation (first introduced in Southeast Asia, 100% embryo survival record), Ion Torrent NGS for concurrent PGT-A/M/HLA from a single biopsy, EmbryoScope+ time-lapse monitoring, AI-enhanced embryo selection using deep learning on embryo imagery, and a dedicated one-incubator-per-patient workflow. Documented pregnancy rates reach 87.5%, comparable to top global IVF centres, with the group reporting 4,600+ newborns, 10,000+ patients, 150+ scientific publications, and multiple world-first fertility breakthroughs.

Commercially, Alpha IVF is a direct-to-consumer professional services provider generating revenue per IVF cycle through owned clinics, with a sales-led go-to-market heavily reliant on health tourism flows from Indonesia and China, formalised via an International Patient Lounge and Malaysia Healthcare Travel Council partnership. 2Q FY2025 revenue was RM43.2 million (+12.2% YoY), 9M FY2025 PATMI was RM41.4 million (+6.3%), and 4Q FY2025 net profit was RM16.07 million (+14.7%), with growth funded in part by March 2024 IPO proceeds being deployed into a multi-country expansion track targeting Indonesia, the Philippines, and China.

Name

Alpha IVF Group

Legal name

Alpha IVF Group Berhad

Website

https://alphaivfgroup.com

Company type

Public

Founded year

2009

Operating status

Operating

Headcount range

51–100 employees

Short description

Alpha IVF Group Berhad is a Malaysia-headquartered fertility healthcare provider operating owned IVF and women's specialist clinics across Malaysia, Singapore, Indonesia, the Philippines, and China, delivering IVF, PGT, and AI-enhanced embryo selection services to domestic and cross-border medical tourism patients.

Ownership category

akta.pro rank

Product category

Fertility Healthcare Services

NAICS

Family Planning Centers (621410)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Fertility/IVF & Reproductive Tourism Agencies (THAKAIAF), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

• Fertility treatment services
• Assisted reproductive technology
• In-vitro fertilization
• Preimplantation genetic testing
• Fertility healthcare clinics

Headquarters

HQ city

Petaling Jaya

HQ country

Malaysia

HQ region

Asia

Offices11 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Fertility Treatment Services: Alpha IVF Group generates revenue primarily through providing assisted reproductive services (IVF, ICSI, PGT, egg freezing, sperm sorting, and related treatments) directly to patients at its owned clinic centres. Revenue is driven by patient volume across its network of fertility centres in Malaysia, Singapore, Indonesia, China, and the Philippines.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels6 records

Core offering

Alpha IVF Group provides assisted reproductive technology (ART) services directly to patients through its owned and operated fertility clinics across Malaysia, Singapore, Indonesia, the Philippines and China. Core services include In-Vitro Fertilisation (IVF), ICSI, Preimplantation Genetic Testing (PGT-A/M/HLA), egg freezing, sperm sorting via MicroSort, implantation optimisation, and In-Vitro Activation (IVA). The group generates revenue through fee-for-service fertility treatment delivery at its network of flagship and satellite centres.

Product overview

Alpha IVF Group is a fertility healthcare provider offering a comprehensive portfolio of assisted reproductive services across Asia-Pacific. The core offering includes In-Vitro Fertilisation (IVF) with advanced technologies such as AI-enhanced embryo selection, Preimplantation Genetic Testing (PGT), PIEZO-ICSI, and CRYOTEC cryopreservation. The group operates multiple clinic brands: Alpha IVF & Women's Specialists (Kuala Lumpur flagship centre with 87.5% success rates), Genesis IVF (Penang), Alhaya Fertility Centre (inclusive Muslim-friendly centre), Alpha IVF (Kota Kinabalu, Singapore, Manila), and satellite clinics in Indonesia (Jakarta, Surabaya, Medan). The group also maintains medical consulting offices in Shanghai and Guangzhou, China. Services include assisted reproductive treatments, PGT (PGT-A/M/HLA), sperm sorting, egg freezing, implantation optimisation, and In-Vitro Activation (IVA) for low ovarian reserve patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Assisted Reproductive Treatments Core fertility treatments including In-Vitro Fertilisation (IVF), ICSI, and Frozen Embryo Transfer (FET) delivered at owned and operated fertility clinic centres for couples and individuals seeking parenthood.
• Preimplantation Genetic Testing (PGT) Embryo screening service offering PGT-A for aneuploidy, PGT-M for monogenic disorders, and PGT-HLA for HLA matching, performed concurrently from a single biopsy to improve pregnancy success rates and prevent genetic disease transmission.
• Implantation Optimisation Treatment approach designed to increase the chances of successful embryo implantation and pregnancy during IVF cycles.
• Sperm Sorting (MicroSort) Sperm sorting service using MicroSort International technology to identify optimal sperm for fertilisation, offered as pioneers in Asia and Australia for this technique.
• Egg Freezing (Oocyte Cryopreservation) Egg retrieval, vitrification and storage service using CRYOTEC freezing technology for future fertility preservation.
• In-Vitro Activation (IVA) Advanced treatment for women with low ovarian reserve, involving ovarian tissue activation to rejuvenate ovaries and improve fertility outcomes.

Quantifiable outcome

• 87.5% documented pregnancy rate (comparable to top IVF centres globally)
• +6 more outcomes

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature11 records

Partnerships

Six partnerships are on record, tiered core, major and minor.

• PT Surya Inter WiesacoreOthers · 17 March 2026Alpha IVF Group's Indonesian subsidiary PT Alpha IVF Dan SPOG Jakarta entered into a clinical space lease agreement with PT Surya Inter Wiesa for a new IVF centre at Bumi Serpong Damai City within Banten's Special Economic Zone. Facility expected to begin operations October 2026.
• InnoquestmajorStrategic or Co-development Partner · 5 September 2025Alpha IVF & Women's Specialists partnered with Innoquest to establish Malaysia's First In-House Diagnostic Lab in a Stand-Alone IVF Centre. The partnership enhances diagnostic capabilities and supports the group's medical tourism strategy.
• PT Alpha IVF Dan SPOG BalicoreStrategic or Co-development Partner · 22 July 2025Alpha IVF Group formed a joint venture to establish PT Alpha IVF Dan SPOG Bali, a fertility centre of excellence in Bali's Sanur Special Economic Zone. Construction underway, expected to start operations in 2027.
• Womba Women's and Children's Specialist Clinic (Surabaya)minorChannel Partner/ Reseller/ Distributor · 22 July 2025Alpha IVF Group's second satellite clinic in Indonesia is located within the Womba Women's and Children's Specialist Clinic in Surabaya. Womba serves as the host clinic for the satellite location.
• Malaysia Healthcare Travel Council (MHTC)majorGTM or Marketing PartnerMHTC attended the Alhaya Fertility Centre grand opening ceremony. MHTC is the government body promoting Malaysia as a healthcare travel destination, supporting Alpha IVF Group's international patient strategy.
• Tunku Azizah Fertility Foundation (TAFF)minorOthersAlhaya Fertility Centre sponsored infertility treatment for three couples from Tunku Azizah Fertility Foundation during its grand opening ceremony.

Scale indicators17 records

Recent moves14 records

Expansion highlights6 records

Broad incumbents

• Bumrungrad International Hospital: Thailand-based multi-specialty hospital with established fertility centre and strong medical-tourism franchise; broader portfolio than Alpha IVF but directly competes for Indonesian, Chinese, and Middle East cross-border fertility patients.
• Bangkok IVF Center (Bangkok Hospital): Thai fertility provider within Bangkok Hospital network, serving regional medical-tourism patients; broader healthcare group but overlapping IVF, ICSI, and PGT services targeting the same Southeast Asian patient base.

Others

• Genea Biomedx: ART technology and consumables provider supplying embryology lab equipment and time-lapse systems used by IVF clinics including Alpha IVF; relevant as a comparable vendor in the fertility-tech stack and EmbryoScope-adjacent ecosystem.

Emerging players

• Safe Fertility Center: Thailand-based fertility provider with PGT and ICSI capabilities; emerging player that intersects with Alpha IVF's regional positioning, particularly for cross-border patients from Indonesia and Indochina.
• Morula IVF (Bundamedik Healthcare System): Indonesian fertility network with multiple clinics; competes with Alpha IVF for the Indonesian outbound patient pool while also serving as a potential referral partner for Alpha IVF's Malaysia-based flagship treatment centres.

Direct peers

• Raffles Fertility Centre: Singapore-based fertility service within Raffles Medical Group; competes directly with Alpha IVF Singapore in the premium cross-border fertility market, especially for Indonesian and Chinese patients seeking treatment in Singapore.
• Sunfert International: Malaysian fertility group operating fertility centres in Kuala Lumpur, Bangi, and Ipoh with PGT and ICSI services; competes head-to-head with Alpha IVF on technology, success rates, and Indonesian medical-tourism patients.
• Thomson Fertility: Malaysia-based fertility provider (part of TMC Life Sciences/Thomson Hospital group) offering IVF, ICSI, and PGT; competes with Alpha IVF for Malaysian and Indonesian patients in the Klang Valley.
• TMC Fertility (TMC Life Sciences): Malaysia-based fertility chain with multiple IVF centres and women's health services, directly competing with Alpha IVF's domestic flagship clinics on success rates, technology stack, and cross-border patient mix.
• Virtus Health (IVFAustralia / Singapore): Asia-Pacific fertility operator with clinics in Australia, Singapore, and Ireland; comparable specialty outpatient fertility model, similar multi-country footprint, and overlapping target patient segments in regional fertility care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@alphaivfwomensspecialists7932
• LinkedInlinkedin.com/company/alpha-ivf-group

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alpha IVF Group